Digital obsessive-compulsive disorder (OCD) identification and management platform NOCD closed a $35 million funding round co-led by Cigna Ventures and 7wireVentures.
Existing investors F-Prime Capital, Kaiser Permanente Ventures, Health Enterprise Partners and Eight Roads Capital also participated in the round alongwith new investor Longitude Capital.
The Chicago-based company provides video-based OCD treatment using the exposure and response prevention technique, a method of behavioral therapy that exposes a person to a situation that provokes an OCD response and learning to tolerate those stressors.
The company will use the funds to continue expanding its network of therapists and further marketing efforts with comedian and TV personality Howie Mandel. The company will also work to enhance its analytics capabilities.
“Cigna Ventures is focused on working with companies who are bringing forward innovative solutions that can more effectively and efficiently solve some of health care’s biggest challenges,” Craig Cimini, head of Cigna Ventures, said in a statement. “NOCD plays a critical role in the behavioral health ecosystem with a proven ability to identify patients in need and seamlessly connect them to evidence-based therapy and tailored resources.”
The latest funding round follows NOCD’s announcements in August that members of Aetna Insurance and Blue Cross Blue Shield of New York would have access to NOCD’s platform.
Calif.-based diagnostics startup Simple HealthKit garnered $8 million in Series A funding, bringing its total raise to $12 million.
The round was led by Initialized Capital with participation from Kleiner Perkins, Quest Venture Partners and Kapor Capital.
Simple HeathKit offers testing for sexual health, respiratory illnesses and chronic conditions like diabetes for home, clinic or pharmacy use with recommendations for consultation and treatment upon a positive test result.
The funding will help Simple HealthKit expand its testing portfolio and bring its platform to underserved markets.
New York-based children’s mental health platform Fort Health announced a $4.5 million raise from Blue Venture Fund.
Fort Health was developed at Redesign Health in partnership with the Child Mind Institute, a nonprofit that focuses on helping children with mental health and learning disorders. The startup offers a platform that connects primary care and behavioral health providers to improve access to mental healthcare for children.
Fort Health is covered under Aetna, Optum/United Healthcare and Geisinger Health Plan commercial insurance in New Jersey. The company says it plans to expand to New York and other states this year.
The new funds will be used to drive the company’s market expansion.
Newel Health received a $2.5 million grant from the Michael J. Fox Foundation for Parkinson’s Research to further research and develop Soturi, the company’s platform for patients with Parkinson’s Disease.
Soturi offers physical, voice and speech exercises and anxiety support as well as symptom tracking, medication reminders and a wearable bracelet that can detect tremors.
Newel was built from an investment by Italy-based Healthware Ventures, the corporate VC of Healthware Group.
“This grant from The Michael J. Fox Foundation marks the first of many important milestones for the company as it continues to develop its portfolio of digital solutions so that the health journeys of people living with health conditions and their doctors’ efforts will become as clear and successful as can be,” Roberto Ascione, chairman of the board of Healthware Ventures, said in a statement.
Canadian healthcare tech startup The Rounds, which offers a network for healthcare professionals across North America to connect and discuss medical topics, garnered an additional $1.6 million CAD ($1.19 million) in Series A funding.
The latest funds from Atlanta-based Panoramic Ventures and Invest Nova Scotia bring the company’s Series A round to $6.7 million CAD ($4.99 million). The company announced a $5.1 million raise in September.
“Our team at Invest Nova Scotia is proud to be a long-time supporter of, and investor in, The Rounds. The Series A fundraise will help replicate the company’s success in Canada across key healthcare markets in the U.S. There has never been a better time to break down the geographic barriers stifling collaboration in specialty healthcare, and The Rounds is doing just that,” Ben McDade, investment principal at Invest Nova Scotia, said in a statement.